Overexpression of IL-8 and its receptors parallel tumor progression, metastatic potential and angiogenesis in human melanoma [62,63,64], and neutralizing antibodies against IL-8 receptors inhibit melanoma angiogenesis [63,65]. Here, CXCL8 is linked to neoplasm.